Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
- PMID: 35830209
- PMCID: PMC9433079
- DOI: 10.1097/CM9.0000000000002161
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Abstract
Background: Non-smokers account for a large proportion of lung cancer patients, especially in Asia, but the attention paid to them is limited compared with smokers. In non-smokers, males display a risk for lung cancer incidence distinct from the females-even after excluding the influence of smoking; but the knowledge regarding the factors causing the difference is sparse. Based on a large multicenter prospective cancer screening cohort in China, we aimed to elucidate the interpretable sex differences caused by known factors and provide clues for primary and secondary prevention.
Methods: Risk factors including demographic characteristics, lifestyle factors, family history of cancer, and baseline comorbidity were obtained from 796,283 Chinese non-smoking participants by the baseline risk assessment completed in 2013 to 2018. Cox regression analysis was performed to assess the sex difference in the risk of lung cancer, and the hazard ratios (HRs) that were adjusted for different known factors were calculated and compared to determine the proportion of excess risk and to explain the existing risk factors.
Results: With a median follow-up of 4.80 years, 3351 subjects who were diagnosed with lung cancer were selected in the analysis. The lung cancer risk of males was significantly higher than that of females; the HRs in all male non-smokers were 1.29 (95% confidence interval [CI]: 1.20-1.38) after adjusting for the age and 1.38 (95% CI: 1.28-1.50) after adjusting for all factors, which suggested that known factors could not explain the sex difference in the risk of lung cancer in non-smokers. Known factors were 7% (|1.29-1.38|/1.29) more harmful in women than in men. For adenocarcinoma, women showed excess risk higher than men, contrary to squamous cell carcinoma; after adjusting for all factors, 47% ([1.30-1.16]/[1.30-1]) and 4% ([7.02-6.75]/[7.02-1])) of the excess risk was explainable in adenocarcinoma and squamous cell carcinoma. The main causes of gender differences in lung cancer risk were lifestyle factors, baseline comorbidity, and family history.
Conclusions: Significant gender differences in the risk of lung cancer were discovered in China non-smokers. Existing risk factors did not explain the excess lung cancer risk of all non-smoking men, and the internal causes for the excess risk still need to be explored; most known risk factors were more harmful to non-smoking women; further exploring the causes of the sex difference would help to improve the prevention and screening programs and protect the non-smoking males from lung cancers.
Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.
Conflict of interest statement
None.
Figures



Similar articles
-
[Body mass index and cancer incidence:a prospective cohort study in northern China].Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Mar;35(3):231-6. Zhonghua Liu Xing Bing Xue Za Zhi. 2014. PMID: 24831616 Chinese.
-
Gender-specific outcomes of low-dose computed tomography screening for lung cancer detection: A retrospective study in Chinese never-smoker population.Cancer Med. 2024 Sep;13(18):e70184. doi: 10.1002/cam4.70184. Cancer Med. 2024. PMID: 39342623 Free PMC article.
-
Hazard Ratio of Smoking on Lung Cancer in Korea According to Histological Type and Gender.Lung. 2016 Apr;194(2):281-9. doi: 10.1007/s00408-015-9836-1. Epub 2015 Dec 31. Lung. 2016. PMID: 26718701
-
[Novel epidemiology in lung cancer - non-smokers, women and cannabis].Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S10-5. Rev Mal Respir. 2007. PMID: 18235388 Review. French.
-
Facing an un-met need in lung cancer screening: The never smokers.Crit Rev Oncol Hematol. 2024 Oct;202:104436. doi: 10.1016/j.critrevonc.2024.104436. Epub 2024 Jul 6. Crit Rev Oncol Hematol. 2024. PMID: 38977146 Review.
Cited by
-
Exosomal epidermal growth factor receptor is involved in HPV-16 E7-induced epithelial-mesenchymal transition of non-small cell lung cancer cells: A driver of signaling in vivo.Cancer Biol Ther. 2022 Dec 31;23(1):1-13. doi: 10.1080/15384047.2022.2133332. Cancer Biol Ther. 2022. PMID: 36224722 Free PMC article.
-
Cost-effectiveness analysis of penpulimab plus carboplatin-paclitaxel as first-line treatment for metastatic squamous non-small-cell lung cancer in China.Health Econ Rev. 2025 Jul 12;15(1):60. doi: 10.1186/s13561-025-00656-1. Health Econ Rev. 2025. PMID: 40646431 Free PMC article.
-
Sintilimab with two cycles of chemotherapy for the treatment of advanced squamous non-small cell lung cancer: a phase 2 clinical trial.Nat Commun. 2024 Feb 19;15(1):1512. doi: 10.1038/s41467-024-45769-z. Nat Commun. 2024. PMID: 38374204 Free PMC article. Clinical Trial.
-
Global burden of lung cancer in 2022 and projected burden in 2050.Chin Med J (Engl). 2024 Nov 5;137(21):2577-2582. doi: 10.1097/CM9.0000000000003268. Epub 2024 Sep 24. Chin Med J (Engl). 2024. PMID: 39313774 Free PMC article.
-
The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035.Front Oncol. 2025 Jan 3;14:1511530. doi: 10.3389/fonc.2024.1511530. eCollection 2024. Front Oncol. 2025. PMID: 39830644 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71:209–249. doi: 10.3322/caac.21660. - PubMed
-
- Kerpel-Fronius A, Tammemägi M, Cavic M, Henschke C, Jiang L, Kazerooni E, et al. . Screening for lung cancer in individuals who never smoked: an international association for the study of lung cancer early detection and screening committee report. J Thorac Oncol 2022; 17:56–66. doi: 10.1016/j.jtho.2021.07.031. - PubMed
-
- Corrales L, Rosell R, Cardona AF, Martín C, Zatarain-Barrón ZL, Arrieta O. Lung cancer in never smokers: the role of different risk factors other than tobacco smoking. Crit Rev Oncol Hematol 2020; 148:102895.doi: 10.1016/j.critrevonc.2020.102895. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical